Tracie Oliver, Chief Commercial Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 74 shares at $33.89 ($3K) on 2024-01-05, disclosed to the SEC on 2024-01-08.
Scheduled sale ($3k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |